Purple Biotech Ltd
PPBT
$2.99
$0.072.40%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | -139.51% | -10.49% | 38.16% | ||
| Total Depreciation and Amortization | 4.44% | 12.50% | -18.37% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 89.42% | -34.38% | 52.17% | ||
| Change in Net Operating Assets | 41.55% | 29.28% | 25.24% | ||
| Cash from Operations | 21.94% | 1.79% | 38.88% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -57.59% | 576.32% | -47.22% | ||
| Cash from Investing | -58.37% | 576.32% | -47.22% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | 26.42% | -10.42% | -9.09% | ||
| Issuance of Common Stock | 100.45% | -94.94% | 72.47% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 41.54% | 82.89% | -7.34% | ||
| Cash from Financing | 255.34% | -97.39% | 84.58% | ||
| Foreign Exchange rate Adjustments | 418.18% | -- | -100.00% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 36.40% | -182.99% | 280.76% | ||